Skip to main content

Closed

SPRO: Spero Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Operating margin24.7%

ROIC23.9%

Financially safe

Stretched

Debt / equity0.05×

Interest coverage0.0×

Current ratio10.50×

Valuation

Unrated

P/E ratio4.3×

Spero Therapeutics, Inc.

SPRONASDAQ Global Select·USD·Closed

Spero Therapeutics, Inc.

SPRONASDAQ·USD·Closed

$1.23

+6.96%

$1.23

+$0.08 (6.96%)

52W Range

7thpctl

Volume

0.47×avg

Mkt Cap

71.22MUSD

P/E

4.3TTM

Div Yield

–ann

52W Range

7thpctl

Volume

0.47×avg

Market Cap

71.22MUSD

P/E Ratio

4.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings